학술논문

Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress.
Document Type
Journal Article
Source
Journal of Psychopharmacology. Jun2017, Vol. 21 Issue 6, p691-703. 13p.
Subject
*MENTAL depression
*PSYCHOLOGICAL stress
*DEVELOPMENTAL neurobiology
*CELL proliferation
*HIPPOCAMPUS (Brain)
*PSYCHOPHARMACOLOGY
*ANHEDONIA
*ANIMAL experimentation
*ANTIDEPRESSANTS
*CELL differentiation
*CELL physiology
*CELL receptors
*FLUOXETINE
*GROWTH factors
*NARCOTIC antagonists
*OPIOID peptides
*RATS
*SWIMMING
*PHARMACODYNAMICS
PHYSIOLOGICAL effects of antidepressants
Language
ISSN
0269-8811
Abstract
The present study investigated the effect of [Nphe1] Arg14, Lys15-N/OFQ-NH2 (UFP-101), a selective NOP receptor antagonist, in chronic mild stress (CMS) in male Wistar rats. NOP receptor antagonists were reported to elicit antidepressant-like effects in rodents. Our aim was to investigate UFP-101 effects on CMS-induced anhedonia and impairment of hippocampal neurogenesis. UFP-101 (10 nmol/rat intracerebroventricularly) did not influence sucrose intake in non-stressed animals, but reinstated basal sucrose consumption in stressed animals from the second week of treatment. UFP-101 also reversed stress effects in forced swimming test and in open field. Fluoxetine (10 mg/kg intraperitoneally) produced similar effects. Moreover, we investigated whether UFP-101 could affect CMS-induced impairment in hippocampal cell proliferation and neurogenesis, and in fibroblast growth factor (FGF-2) expression. Our data confirm that CMS reduced neural stem cell proliferation and neurogenesis in adult rat hippocampus. Chronic UFP-101 treatment did not affect the reduced proliferation (bromodeoxyuridine-positive cells) observed in stressed animals. However, UFP-101 increased the number of doublecortin-positive cells, restoring neurogenesis. Finally, UFP-101 significantly increased FGF-2 expression, reduced by CMS. These findings support the view that blockade of NOP receptors produces antidepressant-like effects in CMS associated with positive effects on neurogenesis and FGF-2 expression. Therefore, NOP receptors may represent a target for innovative antidepressant drugs. [ABSTRACT FROM AUTHOR]